$4.15
0.020.48%
最終更新: Nov 6, 5:49 PM

The average analyst price target for Artiva Biotherapeutics is $23.43, 451.3% above the current price. Of 6 analysts, 3 rate it Buy and 3 Hold. Targets range from $4 to $40. The latest change came on Oct 29, 2026, when Jefferies downgraded Artiva Biotherapeutics from Buy to Hold with a $4 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months